Skip to main content
2026 Prospectus
The Healthcare ExecutiveExecutive News

Final 2027 outpatient rule eases the 340B cut but speeds the clawback

CMS’s final 2027 outpatient rule softens the planned 340B drug cut but quadruples the annual clawback, so hospital finance teams need to rebuild outpatient revenue forecasts before budgets lock.

Final 2027 outpatient rule eases the 340B cut but speeds the clawback

Executive takeaway

The 340B relief is real but partial, and the accelerated clawback hits every outpatient hospital for years. CFOs should bring a site-level 2027 outpatient forecast to the board before the budget is final.

Article

What CMS finalized

The calendar year 2027 hospital outpatient and ambulatory surgical center rule, released Nov. 4, takes effect Jan. 1. Hospitals that meet quality reporting requirements receive a net 2.3% update: a 3.2% market basket increase less a 0.9 percentage point productivity adjustment.

The headline is 340B. Separately payable drugs acquired through the program will be paid at average sales price minus 28%, rather than the minus 33.4% CMS proposed in July. The rate is now built from HRSA ceiling price data instead of the agency’s acquisition cost survey. Because the change is budget neutral, payment for non-drug items and services rises 7.5%. Rural sole community hospitals, children’s hospitals and PPS-exempt cancer hospitals are exempt, and hospitals outside 340B keep ASP plus 6%.

The clawback is the bigger number

To recoup an estimated $7.8 billion tied to its earlier 340B payment remedy, CMS will reduce the outpatient conversion factor by 2% a year, up from 0.5%. That is less than the 3% CMS floated, and because it applies to the conversion factor itself, it reaches every hospital paid under the OPPS. CMS expects the recoupment to finish by 2031.

Site-neutral payment also widens. Imaging without contrast furnished in grandfathered off-campus departments will be paid at 40% of the OPPS rate, an estimated $260 million reduction in 2027, with rural sole community hospitals exempt. Separately, CMS removes 637 more services from the inpatient-only list, and starting in 2028 each off-campus department will need its own NPI and provider-based attestation.

What leaders should do this quarter

  • Model the net effect by site. For a 340B hospital, the drug cut, the 7.5% lift on services and the 2% conversion factor reduction pull in different directions. Run them together, by department, rather than reading the 2.3% headline.
  • Re-price off-campus imaging. Identify which grandfathered locations bill non-contrast imaging and test whether volume, staffing or ownership structure still makes sense at the lower rate.
  • Prepare for case migration. As more procedures leave the inpatient-only list, expect payers and surgeons to push cases to outpatient and ASC settings. Align capacity and physician partnership plans accordingly.
  • Start the 2028 enrollment work now. Separate NPIs and attestations for each off-campus site will take credentialing, IT and revenue cycle time.

Sources

Quarterly Brief

Get the Quarterly Brief by email.

A practical executive agenda for hospital and health system leaders, four times a year.

Sent by The Healthcare Executive. Unsubscribe at any time. See our Privacy Policy.